SCHEMBL11643241

SCHEMBL11643241

OC1CCc2nc(-c3ccccc3)ccc21

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 2/20 0.48
RAB9A P51151 2/20 0.48
KMT2A Q03164 2/20 0.48
GRM5 P41594 3/20 0.47
KDM6B O15054 1/20 0.41
KDM4C Q9H3R0 1/20 0.41
SLC6A2 P23975 1/20 0.38
SLC6A4 P31645 1/20 0.38
KCNH2 Q12809 1/20 0.38
ASIC3 Q9UHC3 1/20 0.38
GFRA3 O60609 1/20 0.37
RET P07949 1/20 0.37
USP30 Q70CQ3 1/20 0.37
ALDH1A1 P00352 3/20 0.36
MAPT P10636 2/20 0.36
POLB P06746 1/20 0.36
HPGD P15428 1/20 0.36
HSD17B10 Q99714 1/20 0.36
PARP1 P09874 1/20 0.36
MAP2K3 P46734 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11643326 0.90 GRM5 (0.58) MEN1RAB9AKMT2AGRM5KDM6B
SCHEMBL11643668 0.80 MEN1 (0.44) MEN1RAB9AKMT2AGRM5KDM6B
SCHEMBL11643411 0.80 KDM6B (0.44) MEN1RAB9AKMT2AKDM6BKDM4C
SCHEMBL11642866 0.76 MEN1 (0.40) MEN1RAB9AKMT2AKDM6BKDM4C
SCHEMBL11646101 0.75 GRM5 (0.46) MEN1RAB9AKMT2AGRM5KDM6B
SCHEMBL11647451 0.74 KDM6B (0.45) MEN1RAB9AKMT2AGRM5KDM6B
SCHEMBL11648533 0.74 KDM6B (0.45) MEN1RAB9AKMT2AGRM5KDM6B
SCHEMBL11644005 0.74 KDM6B (0.50) MEN1RAB9AKMT2AGRM5KDM6B
SCHEMBL11641009 0.74 MEN1 (0.42) MEN1RAB9AKMT2AKDM6BKDM4C
SCHEMBL28524205 0.73 MEN1 (0.44) MEN1RAB9AKMT2AASIC3GFRA3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4117135-A NOVEL 5,6,7,8-TETRAHYDRO-5-QUINOLINES AND THEIR USE AS ANTI-INFLAMMATORY AGENTS SCHERING, A.G. 1978-09-26 US disclosed